149 related articles for article (PubMed ID: 28587766)
1. Circulating 25-hydroxyvitamin D level and prognosis of lung cancer patients: A systematic review and meta-analysis.
Huang JD; Dong CH; Shao SW; Gu TJ; Hu ZL; Ying J; Zhou DF; Xie YP
Bull Cancer; 2017; 104(7-8):675-682. PubMed ID: 28587766
[TBL] [Abstract][Full Text] [Related]
2. Review: the impacts of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis.
Li M; Chen P; Li J; Chu R; Xie D; Wang H
J Clin Endocrinol Metab; 2014 Jul; 99(7):2327-36. PubMed ID: 24780061
[TBL] [Abstract][Full Text] [Related]
3. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients.
Zhou W; Heist RS; Liu G; Asomaning K; Neuberg DS; Hollis BW; Wain JC; Lynch TJ; Giovannucci E; Su L; Christiani DC
J Clin Oncol; 2007 Feb; 25(5):479-85. PubMed ID: 17290055
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of the prognostic and clinical value of serum 25-hydroxyvitamin D levels in previously untreated lymphoma.
Tao Y; Chen H; Zhou Y; Shi Y
Future Oncol; 2021 May; 17(14):1825-1838. PubMed ID: 33728948
[TBL] [Abstract][Full Text] [Related]
5. The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis.
Huang Y; Wei S; Jiang N; Zhang L; Wang S; Cao X; Zhao Y; Wang P
BMC Cancer; 2018 Dec; 18(1):1235. PubMed ID: 30526532
[TBL] [Abstract][Full Text] [Related]
6. Association of Circulating 25-Hydroxyvitamin D Levels with Colorectal Cancer: An Updated Meta-Analysis.
Xu J; Yuan X; Tao J; Yu N; Wu R; Zhang Y
J Nutr Sci Vitaminol (Tokyo); 2018; 64(6):432-444. PubMed ID: 30606966
[TBL] [Abstract][Full Text] [Related]
7. Circulating 25-hydroxyvitamin D and risk of lung cancer: a dose-response meta-analysis.
Chen GC; Zhang ZL; Wan Z; Wang L; Weber P; Eggersdorfer M; Qin LQ; Zhang W
Cancer Causes Control; 2015 Dec; 26(12):1719-28. PubMed ID: 26358829
[TBL] [Abstract][Full Text] [Related]
8. Serum 25-hydroxyvitamin D levels and prognosis in hematological malignancies: a systematic review and meta-analysis.
Wang W; Li G; He X; Gao J; Wang R; Wang Y; Zhao W
Cell Physiol Biochem; 2015; 35(5):1999-2005. PubMed ID: 25871640
[TBL] [Abstract][Full Text] [Related]
9. Circulating 25-hydroxyvitamin D and lung cancer risk and survival: A dose-response meta-analysis of prospective cohort studies.
Feng Q; Zhang H; Dong Z; Zhou Y; Ma J
Medicine (Baltimore); 2017 Nov; 96(45):e8613. PubMed ID: 29137092
[TBL] [Abstract][Full Text] [Related]
10. Associations of serum 25-hydroxyvitamin D level with incidence of lung cancer and histologic types in Norwegian adults: a case-cohort analysis of the HUNT study.
Sun YQ; Langhammer A; Wu C; Skorpen F; Chen Y; Nilsen TIL; Romundstad PR; Mai XM
Eur J Epidemiol; 2018 Jan; 33(1):67-77. PubMed ID: 29080012
[TBL] [Abstract][Full Text] [Related]
11. Serum 25-hydroxyvitamin D, vitamin A, and lung cancer mortality in the US population: a potential nutrient-nutrient interaction.
Cheng TY; Neuhouser ML
Cancer Causes Control; 2012 Sep; 23(9):1557-65. PubMed ID: 22829430
[TBL] [Abstract][Full Text] [Related]
12. Circulating Vitamin D and Overall Survival in Breast Cancer Patients: A Dose-Response Meta-Analysis of Cohort Studies.
Hu K; Callen DF; Li J; Zheng H
Integr Cancer Ther; 2018 Jun; 17(2):217-225. PubMed ID: 28589744
[TBL] [Abstract][Full Text] [Related]
13. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J
Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic value of circulating miR-21 for cancer: a systematic review and meta-analysis.
Wang Y; Gao X; Wei F; Zhang X; Yu J; Zhao H; Sun Q; Yan F; Yan C; Li H; Ren X
Gene; 2014 Jan; 533(1):389-97. PubMed ID: 24076132
[TBL] [Abstract][Full Text] [Related]
15. The association of circulating 25-hydroxyvitamin D concentration with peripheral arterial disease: A meta-analysis of observational studies.
Nsengiyumva V; Fernando ME; Moxon JV; Krishna SM; Pinchbeck J; Omer SM; Morris DR; Jones RE; Moran CS; Seto SW; Golledge J
Atherosclerosis; 2015 Dec; 243(2):645-51. PubMed ID: 26554715
[TBL] [Abstract][Full Text] [Related]
16. The relationship between circulating 25-hydroxyvitamin D and survival in newly diagnosed advanced non-small-cell lung cancer.
Vashi PG; Edwin P; Popiel B; Gupta D
BMC Cancer; 2015 Dec; 15():1012. PubMed ID: 26704811
[TBL] [Abstract][Full Text] [Related]
17. Low circulating 25-hydroxyvitamin D level is associated with increased colorectal cancer mortality: a systematic review and dose-response meta-analysis.
Wu G; Xue M; Zhao Y; Han Y; Zhang S; Zhang J; Li C; Xu J
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32686830
[TBL] [Abstract][Full Text] [Related]
18. The association between circulating 25-hydroxyvitamin D and pancreatic cancer: a systematic review and meta-analysis of observational studies.
Shen Y; Xia J; Yi C; Li T; Wang P; Dai L; Shi J; Wang K; Sun C; Ye H
Eur J Nutr; 2024 Apr; 63(3):653-672. PubMed ID: 38170272
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of circulating vitamin D binding protein, total, free and bioavailable 25-hydroxy vitamin D in patients with colorectal cancer.
Yang L; Chen H; Zhao M; Peng P
Oncotarget; 2017 Jun; 8(25):40214-40221. PubMed ID: 28388568
[TBL] [Abstract][Full Text] [Related]
20. Association between Circulating Vitamin D Level and Urolithiasis: A Systematic Review and Meta-Analysis.
Hu H; Zhang J; Lu Y; Zhang Z; Qin B; Gao H; Wang Y; Zhu J; Wang Q; Zhu Y; Xun Y; Wang S
Nutrients; 2017 Mar; 9(3):. PubMed ID: 28335477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]